The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)

• Johannes Brettschneider ,

  * E-mail: johannes.brettschneider@uni-ulm.de

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Anne Czerwoniak,

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Makbule Senel,

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Lubin Fang,

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Jan Kassubek,

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Elmar Pinkhardt,

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Florian Lauda,

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Tamara Kapfer,

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Sarah Jesse,

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Vera Lehmensiek,

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Albert C. Ludolph,

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Markus Otto,

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Hayrettin Tumani

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯